Koshinski Asset Management
RPRX icon

Koshinski Asset Management’s Royalty Pharma RPRX Stock Holding History

Koshinski Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,671
Closed -$324K – 636
2024
Q1 		$324K Sell
10,671
-3,879
-27% -$114K 0.03% 412
2023
Q4 		$409K Buy
14,550
+3,180
+28% +$87.4K 0.06% 317
2023
Q3 		$309K Sell
11,370
-1,530
-12% -$45.4K 0.04% 427
2023
Q2 		$397K Sell
12,900
-1,100
-8% -$37.3K 0.04% 393
2023
Q1 		$504K Hold
14,000
– – 0.05% 325
2022
Q4 		$553K Buy
+14,000
New +$584K 0.05% 345

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Koshinski Asset Management's RPRX Position: Q2 2024 in Review

Koshinski Asset Management sold out of Royalty Pharma (RPRX) in Q2 2024, closing a stake of 10,671 shares — an estimated $324K sold.

Koshinski Asset Management first reported a position in RPRX in Q4 2022 and held it in 6 quarters. The position peaked at $553K in Q4 2022. 378 funds tracked by Wall St. Rank hold RPRX as of Q2 2024.

  • Koshinski Asset Management reported no remaining Royalty Pharma position as of Q2 2024 after selling out during the quarter.
  • Koshinski Asset Management sold 10,671 Royalty Pharma shares in Q2 2024, an estimated $324K.
  • Koshinski Asset Management first reported a position in Royalty Pharma in Q4 2022 and held it in 6 quarters.
  • Koshinski Asset Management's Royalty Pharma position peaked at $553K in Q4 2022.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2024.

Based on Koshinski Asset Management's 13F filing for Q2 2024, filed 12 Jul 2024.